Analysed Astellas Pharma Inc (ALPMF:OTCMKTS) News Sources
Astellas and Vir Biotechnology collaborate to advance PSMA-targeting PRO-XTEN dual-masked T-cell engager VIR-5500 to treat prostate cancer
Pharmabiz
Astellas Pharma Inc.: Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN Dual-masked T-Cell Engager VIR-5500 for the ...
FinanzNachrichten.de
Astellas Pharmaceuticals Enters $1.7 Billion Global Collaboration with Vir Biotechnology to advance PSMA-targeting PRO-XTEN
PharmExec
Why Ironwood Pharmaceuticals, Inc.’s (IRWD) Stock Is Down 11.08%
American Association of Individual Investors
Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
Yahoo Finance
What is the current price of Astellas Pharma Inc (ALPMF:OTCMKTS)?
The current price of Astellas Pharma Inc (ALPMF:OTCMKTS) is $15.675.
Astellas Pharma Inc (ALPMF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of Astellas Pharma Inc (ALPMF:OTCMKTS) since the previous trading day is $-1.46.
Astellas Pharma Inc (ALPMF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of Astellas Pharma Inc (ALPMF:OTCMKTS) since the previous trading day is -8.55%.
What is This Week's average sentiment score for Astellas Pharma Inc (ALPMF:OTCMKTS)?
This Week's average sentiment score for Astellas Pharma Inc (ALPMF:OTCMKTS) is 84 out of 100.
What is This Week's average sentiment for Astellas Pharma Inc (ALPMF:OTCMKTS)?
This Week's sentiment for Astellas Pharma Inc (ALPMF:OTCMKTS) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.